Table 1. Deregulation of S100A14 in human cancers.
| Cancer type | Source | mRNA/protein | Up/downregulation (cancer versus normal) | Ref. |
|---|---|---|---|---|
| OSCC | Cultured cells/Tissue | mRNA and protein | Down | [9, 10, 66] |
| Gastrointestinal cancer | ||||
| Esophageal sq. cell carcinoma | Tissue | mRNA and protein | Down | [71, 73] |
| Small intestinal adenocarcinoma | Tissue | Protein | Down | [76] |
| Colorectal carcinoma | Tissue | mRNA and protein | Down | [3, 77] |
| Ovarian cancer | ||||
| Epithelial ovarian cancer | Cultured cells/Tissue | mRNA and protein | Up | [3, 78] |
| Serious ovarian cancer | Tissue/Serum | Protein | Up | [79] |
| Cervical cancer | Tissue | Protein | Up | [93] |
| Breast cancer | Tissue | mRNA and Protein | Up | [3, 81] |
| Breast cancer | Tissue | Protein | Up | [54] |
| Lung adenocarcinoma | Tissue/Serum | Protein | Up | [83] |
| Lung adenocarcinoma | Tissue | Protein | Up | [84, 85] |
| Hepatocellular carcinoma | Tissue | Protein | Up | [82] |
| Uterine cancer | Tissue | mRNA | Up | [3] |
| Renal cancer | Tissue | mRNA | Down | [3] |
| Bladder cancer | Tissue | mRNA | Up | [80] |
Down: downregulation; Up: upregulation.